Product Description

🔹 Product Overview
Nindanib 150 mg Capsule is a prescription anti-fibrotic medicine used to treat certain progressive lung diseases.
Contains Nintedanib 150 mg, a tyrosine kinase inhibitor that helps slow the progression of lung scarring and fibrosis.
Commonly prescribed for patients with Idiopathic Pulmonary Fibrosis (IPF) and other chronic fibrosing interstitial lung diseases.

🔹 Key Uses
Treatment of Idiopathic Pulmonary Fibrosis (IPF)
Management of progressive fibrosing interstitial lung diseases (ILDs)
Used in systemic sclerosis-associated interstitial lung disease (SSc-ILD)
May be prescribed in specific cases of non-small cell lung cancer (NSCLC) under specialist supervision.

🔹 Composition
Active ingredient: Nintedanib 150 mg
Belongs to the Tyrosine Kinase Inhibitor (TKI) class
Used in anti-fibrotic and targeted therapy treatment.

🔹 How It Works
Blocks specific growth factor receptors involved in fibrosis and abnormal tissue repair.
Helps reduce lung scarring and slows disease progression.
Supports preservation of lung function in patients with chronic fibrotic lung disorders.

🔹 Key Benefits
Effective Idiopathic Pulmonary Fibrosis treatment
Helps slow the decline of lung function
Supports management of chronic fibrosing lung diseases
Targeted mechanism of action for long-term disease control

🔹 Dosage and Administration
Take exactly as prescribed by a healthcare professional.
Usually taken twice daily with food, approximately 12 hours apart.
Swallow the capsule whole with water.
Do not crush, chew, or open the capsule.

🔹 Possible Side Effects
Diarrhea
Nausea and vomiting
Abdominal pain
Loss of appetite
Headache
Elevated liver enzymes.

🔹 Precautions
Use only under specialist medical supervision.
Regular monitoring of liver function may be required.
Inform your doctor about liver disease, kidney disease, or bleeding disorders.
Avoid use during pregnancy unless specifically advised by a healthcare provider.
Inform your doctor about all medications being taken to avoid interactions.